RE: why can't we go it alone?5 Feb 2023 10:49
I agree. If AVA6000 proves to be as good as the early signs are showing, it would be a great shame for shareholders bank balances, but great news for cancer sufferers, if Big Pharma took it off our hands now and ran with it with all their financial firepower and took it to market as quickly as possible for the good of patients. If the same followed for multiple ProDrug candidates leaving Avacta with a war chest to concentrate on TMAC and the remaining candidates, then it would, in my opinion, be the fastest way to a multi billion Mcap and the quickest way for patients to access pre|CISION. I know Alan said they wouldn’t licence out their first candidate, but IMO they should. For the right price obviously.